DelistingSep 11, 2026, 04:17 PM
Fractyl Health Faces Nasdaq Delisting; Seeks Hearing, Reverse Split
AI Summary
Fractyl Health, Inc. has received a formal notice from Nasdaq indicating its common stock is subject to delisting due to failing to meet the minimum bid price requirement of $1.00 per share for 30 consecutive business days. The company did not regain compliance within the allotted grace period. Fractyl Health plans to request a hearing before the Nasdaq Hearings Panel, which will temporarily halt the delisting process. To address the issue, the company is also seeking shareholder approval for a reverse stock split.
Key Highlights
- Fractyl Health received a Nasdaq delisting notice due to bid price falling below $1.00 for 30 consecutive days.
- The company did not regain compliance within the 180-day grace period ending September 9, 2026.
- Fractyl Health intends to request a hearing before the Nasdaq Hearings Panel to avoid delisting.
- A hearing request will stay the delisting process pending the panel's decision.
- To regain compliance, the stock must trade at $1.00 or higher for 10-20 consecutive business days.
- The company is seeking stockholder approval for a reverse stock split (1-for-5 to 1-for-15) to address the bid price issue.
Price Impact
More from GUTS